Tryp Therapeutics Inc. announced that Mr. David L. Tousley, CPA, MBA, has been appointed as a new independent director to replace William Garner, M.D., who stepped down from the Tryp Board of Directors in connection with his investment in the Company's previously announced non-brokered private placement (the "Private Placement").
Tryp Therapeutics Inc. Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | -.--% | -.--% | +50.00% |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TYP Stock
- TRYP Stock
- News Tryp Therapeutics Inc.
- Tryp Therapeutics Inc. Announces Board Changes